Company news
Crescita Therapeutics, Inc. news in 2017
Crescita Therapeutics, Inc.'s news releases, calls and decks from 2017, newest first.
Crescita Therapeutics(TM) Announces 2017 Third Quarter Results and Appoints New CFO
November 10, 2017
Crescita Therapeutics(TM) Reports Positive Topline Results of Phase 2 Clinical Trial for the Treatment of Plaque Psoriasis
September 18, 2017
Crescita Therapeutics(TM) Announces Completion of $1.0 million Convertible Debenture Financing with Bloom Burton Funds
August 29, 2017
Crescita Therapeutics(TM) Announces Profitable 2017 Second Quarter Results
August 14, 2017
Crescita Therapeutics(TM) Announces Amended Loan Agreement with Knight Therapeutics
August 14, 2017
Crescita Therapeutics(TM) Announces Acquisition of Alyria® Skincare Products
August 8, 2017
Crescita Therapeutics(TM) Announces 2017 First Quarter Results
May 15, 2017
Crescita Therapeutics(TM) Announces Agreement with Taro Pharmaceuticals for Pliaglis®
April 25, 2017
Crescita Therapeutics(TM) Announces the Appointment of a New President
April 12, 2017
Crescita Therapeutics(TM) Announces 2016 Fourth Quarter and Year-End Results
March 30, 2017
Crescita Therapeutics(TM) Announces Signing of a Licensing Agreement Utilizing its MMPE(TM) Technology
March 21, 2017
Crescita Therapeutics(TM) Announces Management and Board Changes
February 10, 2017
Crescita Therapeutics(TM) Announces Launch of ISDIN® Product Line at Brunet Pharmacy
January 26, 2017